Bactiguard Holding ABCHIX:BACTBS 52 Days Payable is 401.08 as of Mar. 2026, which is 199% above its 10-year median of 133.94. GuruFocus rates CHIX:BACTBS with a GF Score™ of 52/100 and a GF Value™ of kr274.02. The stock has 2 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Bactiguard Holding AB ranks better than 87.81% on this metric.
The historical rank and industry rank for Bactiguard Holding AB's Days Payable or its related term are showing as below:
CHIX:BACTBs'
s Days Payable Range Over the Past 10 Years
Min: 84.33 Med: 133.94 Max: 281.53
Current: 281.53
During the past 13 years, Bactiguard Holding AB's highest Days Payable was 281.53. The lowest was 84.33. And the median was 133.94.
CHIX:BACTBs's Days Payable is ranked better than 87.81% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 68.14
vs CHIX:BACTBs: 281.53
Bactiguard Holding AB Days Payable Historical Data
* Premium members only.
The historical data trend for Bactiguard Holding AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:BACTBS vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Bactiguard Holding AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bactiguard Holding AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Bactiguard Holding AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bactiguard Holding AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bactiguard Holding AB (CHIX:BACTBS) has a Days Payable of 401.08 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bactiguard Holding AB and its competitors. This is 199% above median its historical median of 133.94. Over the past decade, Bactiguard Holding AB's Days Payable has ranged from 84.33 to 281.53. According to the industry distribution chart, Bactiguard Holding AB ranks #97 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 12.2%.
Is Bactiguard Holding AB's Days Payable too high?
Bactiguard Holding AB's current Days Payable of 401.08 is 199% above median its 10-year median of 133.94. Over the past 10 years, this metric has ranged from a low of 84.33 to a high of 281.53. The Medical Devices & Instruments industry median Days Payable is 68.14. Bactiguard Holding AB's value of 401.08 is 488.6% above this industry median. Based on the distribution chart, Bactiguard Holding AB ranks #97 out of 796 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bactiguard Holding AB has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bactiguard Holding AB ranks #97 out of 796 companies for Days Payable. This places Bactiguard Holding AB in the top 12% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.14. Bactiguard Holding AB's value of 401.08 is 488.6% above this benchmark. Historically, Bactiguard Holding AB's own Days Payable has ranged from 84.33 to 281.53 over the past decade. While the company's 10-year median is 133.94 vs. the industry median of 68.14, Bactiguard Holding AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.14, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bactiguard Holding AB's current Days Payable of 401.08 is 488.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bactiguard Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bactiguard Holding AB's current Days Payable is 401.08, which is 199% above median its own 10-year median of 133.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current Days Payable of 401.08. The stock's GF Value™ is kr274.02, compared to a current price of kr128.60 — trading 53.1% below its estimated fair value. The current Days Payable is 401.08, which is 199% above median its 10-year median of 133.94 and 488.6% above the Medical Devices & Instruments industry median of 68.14. Bactiguard Holding AB's overall GF Score™ is 52/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current Days Payable is 401.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued.
The current stock price of kr128.60 is trading 53.1% below its estimated GF Value™ of kr274.02.
Key valuation signals for CHIX:BACTBS:
Days Payable: 401.08 (199% above median its 10-year median of 133.94)
GF Value™: kr274.02 vs. price of kr128.60 (53.1% below fair value)
Industry Position: 488.6% above the Medical Devices & Instruments median (#97 of 796)
No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
52GF Score
Get the complete analysis for CHIX:BACTBS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BACTBS has been successfully added to your 
